Patents Examined by S. Nolan
  • Patent number: 11383728
    Abstract: A multimodal sensing system for agricultural machines may include an agricultural machine operable in a first operating mode and a second operating mode and a sensor which is movable to adjust its field-of-view between a first field-of-view and a second field-of-view depending on the operating mode of the agricultural machine. The sensor may be configured to generate sensor data associated with the first field-of-view when the agricultural machine is operating in the first operating mode and generate sensor data associated with the second field-of-view when the agricultural machine is operating in the second operating mode. A controller may analyze the sensor data generated when the sensor has the first and second field-of-views so as to provide respective first and second output signals associated with the first and second operating modes, respectively, of the agricultural machine.
    Type: Grant
    Filed: March 14, 2019
    Date of Patent: July 12, 2022
    Assignee: CNH Industrial America LLC
    Inventor: Trevor Stanhope
  • Patent number: 5139944
    Abstract: The collagenase is like tissue collagenases in that it cleaves collagen at a single site. The collagenase which has a molecular weight of about 50 k daltons, specifically inhibits collagen-induced platelet aggregation, with substantially no effect on platelet count or size, and may be used alone or together with another platelet aggregation inhibitor. The latter may also be a leech-derived biochemical, such as an apyrase, or an inhibitor of the release of platelet aggregation factor by leucocytes.
    Type: Grant
    Filed: January 30, 1991
    Date of Patent: August 18, 1992
    Assignees: Biophram (UK) Limited, Yissum Research Development Company of the Hebrew University of Jerusalem
    Inventors: Roy T. Sawyer, Meir Rigbi, Haim Levy, Fuad Iraqi
  • Patent number: 5104806
    Abstract: An analog of porcine growth hormone, is disclosed which retains the diabetogenic, insulin-sparing and lipolytic properties of porcine growth hormone while being capable of improving growth in mammals.
    Type: Grant
    Filed: March 12, 1987
    Date of Patent: April 14, 1992
    Assignees: Amgen, Inc., SmithKline Beecham Corporation
    Inventor: Lawrence M. Souza
  • Patent number: 5037743
    Abstract: Methods for producing heterologous proteins in a host organism whereby the proteins are processed through the secretory pathway of the host are provided. Secretion is achieved by transforming a host organism with a DNA construct comprising a transcriptional promoter operably linked to DNA sequences encoding a signal peptide, at least a portion of the BAR1 C-terminal domain capable of directing the export of heterologous proteins and a heterologous protein or polypeptide. DNA constructs and transformants are also provided wherein the DNA sequence encoding at least a portion of the C-terminal domain of BAR1 capable of directing the export of heterologous proteins further comprises a DNA sequence encoding a proteolytic cleavage site operably linked to the DNA sequence encoding a heterologous protein.
    Type: Grant
    Filed: November 14, 1988
    Date of Patent: August 6, 1991
    Assignee: ZymoGenetics, Inc.
    Inventors: Susan K. Welch, Vivian L. MacKay, Carli L. Yip
  • Patent number: 5026544
    Abstract: The present disclosure is directed to the use of combinations of a papaverine family member agent together with an interferon for the treatment of proliferative disorders such as neoplasias and hyperplasias. Disclosed are compositions and formulations which take advantage of the synergistic antiproliferative activities of these agents and the use of these compositions and formulations in the treatment of these disorders.
    Type: Grant
    Filed: February 16, 1988
    Date of Patent: June 25, 1991
    Assignee: Board of Reagents, The University of Texas System
    Inventors: Thomas B. Albrecht, Thomas E. Albrecht, William R. Fleischmann
  • Patent number: 5017477
    Abstract: A bacterial cell transformed with a gene encoding a desired product and with an enhancing DNA sequence capable of enhancing the production of the desired product in the bacterial cell, the enhancing DNA sequence being further characterized in that it is capable of enhancing the production of an endogenous protease in a Gram-positive bacterial cell.
    Type: Grant
    Filed: October 20, 1986
    Date of Patent: May 21, 1991
    Assignee: BioTechnica International, Inc.
    Inventors: Alan Sloma, Rosalind C. Lee, Janice Pero
  • Patent number: 5010001
    Abstract: Enhanced production of B. thuringiensis delta-endotoxin is achieved by employing the naturally occurring gene where an abbreviated 3'- and 5'-non-coding flanking region is employed. Particularly, the 3'-flanking does not extend past the downstream HincII cleavage site and the 5'-flanking region does not extend past the upstream HincII cleavage site. By having abbreviated flanking regions, enhanced production of the delta-endotoxin in E. coli is obtained.
    Type: Grant
    Filed: March 28, 1985
    Date of Patent: April 23, 1991
    Assignee: Syntro Corporation
    Inventor: Thomas J. Pollock
  • Patent number: 4970155
    Abstract: This invention encompasses an eukaryotic expression vector constructed from a prokaryotic plasmid by inserting into the prokaryotic plasmid a mediator sequence and a promoter/regulatory sequence with a restriction endonuclease site for inserting a gene to be expressed. The gene to be expressed is inserted into the restriction endonuclease site in the promoter/regulatory sequence and the resulting plasmid is in turn used to transform a eukaryotic cell. The gene is expressed with or without viral mediation.
    Type: Grant
    Filed: November 23, 1988
    Date of Patent: November 13, 1990
    Assignee: Abbott Laboratories
    Inventor: Gregory F. Okasinski
  • Patent number: 4960877
    Abstract: DNA having a base sequence encoding a specified amino acid sequence of a polypeptide constituting an L-.alpha.-glycerophosphate oxidase (GPO) is disclosed. A polypeptide having the specified amino acid sequence can be produced by inserting the DNA into a plasmid, culturing a transformant produced by introducing this plasmid into a host microorganism which is selected from microorganisms belonging to Escherichia coli, Bacillus subtilis, or Saccharomyces cerevisiae. The GPO is useful for the quantitative analysis of triglyceride, glycerine, etc., and the determination of lipase activity, when used in combination with other enzymes such as lipase, glycerol kinase, or the like, or with an ATP reagent.
    Type: Grant
    Filed: December 12, 1988
    Date of Patent: October 2, 1990
    Assignee: Toyo Jozo Co., Ltd.
    Inventors: Hitoshi Sagai, Keiko Nogata, Mamoru Takahashi
  • Patent number: 4959323
    Abstract: In accordance with the present invention, recombinant plasmids are described which, when inserted into microbial hosts, direct the synthesis of proteins in which preS polypeptides found on the surface of human hepatitis B virus are fused to the enzyme .beta.-galactosidase. The recombinant plasmids are produced by inserting DNA sequences encoding the preS polypeptides into the lacZ gene, which codes for E. coli .beta.-galactosidase, carried by the plasmids. Large amounts of the preS-.beta.-galactosidase fusion proteins can be isolated from microbial cultures carrying the recombinant plasmids. Antigenic determinants of fusion protein so produced are recognized by antibodies to the preS determinants of native hepatitis B virus. The .beta.-galactosidase activity of such fusion protein is detected by a suitable chromogenic or fluorogenic substrate. PreS-.beta.
    Type: Grant
    Filed: November 4, 1985
    Date of Patent: September 25, 1990
    Assignee: Mt. Sinai School of Medicine of the City University of New York
    Inventors: George Acs, Judith K. Christman, Peter Price, Wolf Offensperger, Silke Wahl
  • Patent number: 4933286
    Abstract: An isoenzyme from tomato, acid phosphatase-1 isoenzyme (Apase-1.sup.1), has ben purified to homogeneity and is subjected to amino acid sequencing and used to prepare anti-Apase-1 antibodies. The amino acid sequence permits design of probes to recover Apase-1.sup.1 -encoding cDNA; the antibodies are also useful for this purpose. The cDNA is useful to recover the genomic DNA encoding Apase-1.sup.1, which can then be used in walking or jumping techniques to recover the genomic DNA which confers nematode resistance, since this DNA resides immediately adjacent to the Apase-1.sup.1 gene on chromosome 6 of Lycopersicon esculentum.
    Type: Grant
    Filed: March 30, 1987
    Date of Patent: June 12, 1990
    Assignee: Plant Cell Research Institute, Inc.
    Inventors: Elizabeth M. Paul, Valerie M. Williamson, Jack L. Erion, Candace G. Poutre